Sjogren's Syndrome
162
30
40
79
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
14 trials with published results (9%)
Research Maturity
79 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.9%
8 terminated out of 162 trials
90.8%
+4.3% vs benchmark
10%
17 trials in Phase 3/4
18%
14 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (162)
Wheat-free Diet in the Treatment of Sjogren's Syndrome
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
Characterization of Diseases With Salivary Gland Involvement
The Pathogenesis and Natural History of Sjogren's Disease
Nipocalimab in Moderate to Severe Sjogren's Disease
Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Aerobic Exercise in Primary Sjögren's Syndrome
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Efficacy and Safety of Baricitinib in Sjogren's Syndrome
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Penn SICCA Follow-up Study
Rheumatology Patient Registry and Biorepository
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
Maternal Autoimmune Disease Research Alliance (MADRA) Registry